European shares were muted on Monday, with declines in consumer-facing stocks offsetting gains in industrials and healthcare stocks, while investors awaited the U.S. Federal Reserve’s monetary policy meeting this week.Read More

Wakefit’s IPO opened to a subdued 11% Day 1 subscription, with retail showing moderate interest and institutions staying away. Despite a positive GMP hinting at a premium listing, concerns persist over ongoing losses, high costs and limited operating leverage.Read More

Indian markets opened muted, with Nifty hovering near 26,000 as momentum cooled post-record highs. Broader markets face strain, prompting caution. Analysts suggest Nifty will consolidate between 25,850 and 26,300. Investors are advised to be selective, buying dips and booking profits, with HDFC Life and BPCL identified as strong performers.Read More

Ravelcare, a Shark Tank India-featured startup, made a strong public market debut on December 8, delivering a 55% listing gain after its IPO was priced at Rs 130 per share. The company raised Rs 24.10 crore through a 100% fresh issue, which saw overall subscription of 437.6 times, reflecting robust demand from retail, NII, and...Read More

Adani Enterprises’ Rs 25,000 crore rights issue is seeing strong traction, with nearly half the bids coming in just two days. The Rights Entitlement price has surged 23%, signalling heightened investor interest. The discounted issue price and partly-paid structure are drawing global and domestic investors ahead of the December 10 RE trading deadline.Read More

IndiGo shares have plunged over 16% in six sessions, erasing Rs 37,000 crore in market value as severe operational disruptions and new FDTL norms trigger widespread cancellations. Brokerages have slashed targets citing rising costs and pilot shortages, though some see long-term strength despite near-term turbulence and regulatory scrutiny.Read More

India’s IPO market has hit an all-time high of ₹1.77 trillion as companies tap strong retail participation and steady institutional demand. Despite muted secondary-market returns and stretched valuations leaving many recent listings below issue price, the fundraising pipeline remains robust with major deals lined up through mid-December and beyond.Read More

Corona Remedies’ IPO opened with decent subscription demand, led by strong retail demand and a robust Rs 290 grey-market premium. The Rs 655-crore issue, priced at Rs 1,008–1,062, signals healthy investor interest ahead of the December 10 close and expected December 15 listing.Read More

NRI demand for Indian residential real estate is rising sharply, with buyers shifting from speculative purchases to long-term, lifestyle-driven investments. Younger global Indians are choosing premium and ultra-luxury homes, boosting sales across markets like Gurgaon, Mumbai, and NCR. Strong rental yields, emotional ties, and retirement planning continue to fuel this growing trend.Read More

Suzlon Energy shares saw a rise following positive analyst outlooks. Experts foresee significant growth driven by strong operational momentum and a growing order book. The company is poised to benefit from increased demand for wind energy. Analysts have reiterated their buy ratings, highlighting potential upside from current market levels. Suzlon’s expansion plans and export market...Read More